Why Repligen Stock Jumped 10.6% On Friday
Shares of Repligen (NASDAQ:RGEN), a leading provider of proteins and filtration technology that is used to manufacture biologic drugs, rose 10.6% on Friday. The jump doesn’t appear to be caused by any company-specific news. Instead, the double-digit increase was most likely caused by the marketwide buying frenzy on Friday. All three major U …
News story posted on 2020-03-15T20:21:00.0000000Z
